| ISIN | LU1495641521 |
|---|---|
| Valor Number | 34048582 |
| Bloomberg Global ID | |
| Fund Name | Swisscanto (LU) Equity Fund Committed Europe Top Dividend DT |
| Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
| Fund Provider | Swisscanto Fondsleitung AG |
| Representative in Switzerland | Swisscanto Fondsleitung AG |
| Distributor(s) | Schweizerische Kantonalbanken |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The sub-fund assets will be invested in an investment universe dedicated to companies with a high dividend yield and which have their registered office or conduct the majority of their business operations in the geographical region referred to in the name of the sub-fund. |
| Peculiarities |
| Current Price * | 277.59 EUR | 20.11.2025 |
|---|---|---|
| Previous Price * | 277.38 EUR | 19.11.2025 |
| 52 Week High * | 286.76 EUR | 12.11.2025 |
| 52 Week Low * | 231.99 EUR | 09.04.2025 |
| NAV * | 277.59 EUR | 20.11.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 74,775,884 | |
| Unit/Share Assets *** | 1,054,358 | |
| Trading Information SIX | ||
| YTD Performance | +13.84% |
31.12.2024 - 20.11.2025
31.12.2024 20.11.2025 |
|---|---|---|
| YTD Performance (in CHF) | +12.52% |
31.12.2024 - 20.11.2025
31.12.2024 20.11.2025 |
| 1 month | -0.42% |
20.10.2025 - 20.11.2025
20.10.2025 20.11.2025 |
| 3 months | -0.03% |
20.08.2025 - 20.11.2025
20.08.2025 20.11.2025 |
| 6 months | +2.33% |
20.05.2025 - 20.11.2025
20.05.2025 20.11.2025 |
| 1 year | +13.63% |
20.11.2024 - 20.11.2025
20.11.2024 20.11.2025 |
| 2 years | +24.55% |
20.11.2023 - 20.11.2025
20.11.2023 20.11.2025 |
| 3 years | +33.07% |
21.11.2022 - 20.11.2025
21.11.2022 20.11.2025 |
| 5 years | +65.59% |
20.11.2020 - 20.11.2025
20.11.2020 20.11.2025 |
| Equity Participation Rate in % | 97.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Novartis AG Registered Shares | 3.71% | |
|---|---|---|
| Allianz SE | 3.61% | |
| Shell PLC | 3.59% | |
| GSK PLC | 3.51% | |
| Aker BP ASA | 3.09% | |
| NN Group NV | 2.96% | |
| Sanofi SA | 2.76% | |
| AXA SA | 2.74% | |
| Zurich Insurance Group AG | 2.67% | |
| BP PLC | 2.53% | |
| Last data update | 31.10.2025 | |
| TER | 0.77% |
|---|---|
| TER date | 31.03.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.00% |
| Ongoing Charges *** | 0.77% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |